CTI BioPharma Corp. (CTIC): Price and Financial Metrics
CTIC Price/Volume Stats
| Current price | $9.09 | 52-week high | $9.10 |
| Prev. close | $9.09 | 52-week low | $4.01 |
| Day low | $9.09 | Volume | 11,420,900 |
| Day high | $9.10 | Avg. volume | 4,496,004 |
| 50-day MA | $7.44 | Dividend yield | N/A |
| 200-day MA | $5.87 | Market Cap | 1.20B |
CTIC Stock Price Chart Interactive Chart >
CTI BioPharma Corp. (CTIC) Company Bio
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The company was founded in 1991 and is based in Seattle, Washington.
Latest CTIC News From Around the Web
Below are the latest news stories about CTI BIOPHARMA CORP that investors may wish to consider to help them evaluate CTIC as an investment opportunity.
Top Small-Cap Stocks for June 2023Biggest movers include Prometheus, TG Therapeutics, and Akero Therapeutics, all more than quadrupling in price in the last year while the Russell 2000 Index stays nearly unchanged. |
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of StockholdersCTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has cancelled the 2023 Annual Meeting of Stockholders (the "Annual Meeting") which was scheduled for June 21, 2023, and has withdrawn the proposals to have been submitted to stockholders at the Annual Meeting. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayIt's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! |
Why Is Babylon (BBLN) Stock Down 57% Today?Babylon (BBLN) stock is falling on Wednesday after the health services company revealed earnings and a plan to go private. |
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?CTI BioPharma (CTIC) stock is taking off on Wednesday after the company announced a major $1.7 billion acquisition deal with Sobi. |
CTIC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 77.89% |
| 3-year | 271.02% |
| 5-year | 821.44% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 142.34% |
| 2021 | -22.98% |
| 2020 | 103.80% |
| 2019 | 116.44% |
Continue Researching CTIC
Want to do more research on Cti Biopharma Corp's stock and its price? Try the links below:Cti Biopharma Corp (CTIC) Stock Price | Nasdaq
Cti Biopharma Corp (CTIC) Stock Quote, History and News - Yahoo Finance
Cti Biopharma Corp (CTIC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...